All In MedTech

Device Trial Radar · NCT04349046

Exception Cementless Hip Stem

Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

332

Planned (sponsor's estimate)

Start

Jan 1, 2021

Primary completion

May 1, 2025

Study completion Dec 2026

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Apr 16, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years

Summary

As written by the sponsor on the registry.

This study is a multicenter, retrospective and prospective, non-controlled, non-randomized post market clinical follow-up study. The objectives of this study are to confirm the long-term safety, performance and clinical benefits the Exception Cementless femoral stem (standard and varized) when used in primary total hip arthroplasty.

Conditions

  • Osteoarthritis, Hip
  • Rheumatoid Arthritis
  • Inflammatory Arthritis
  • Congenital Hip Dysplasia
  • Avascular Necrosis of Hip
  • Femoral Neck Fractures

Interventions

  • Total hip arthoplasty (THA)Device

    Total hip arthroplasty (THA) is a common operative treatment where an arthritic, degenerative or fractured hip joint is replaced with a prosthetic device if conservative options are unable to relieve pain and debilitating symptoms. THA was traditionally performed on patients over 60 years old, but now includes young and active patients, as well as very old ones thanks to the continuous improvement in implant design. Major indications of THA include osteoarthritis, rheumatoid arthritis, avascular necrosis and hip fractures. The THA surgical procedure involves replacing the head of the femur and acetabulum or socket with an artificial prosthesis. This system is composed of a femoral stem that is inserted into the femoral canal, a ball that attaches to the femoral stem, and an acetabular component or shell that replaces the acetabulum.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Implant survival based on removal or intended removal of the device and determined using the Kaplan-Meier methodTime frame: 10 years post-surgery

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Hôpital Princesse Paola

    Aye, Belgium

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.